...
机译:吉西他滨联合顺铂方案对M-VAC方案失败后晚期尿路上皮癌患者的疗效和安全性
Department of Urology, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan;
Department of Urology, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan;
Department of Urology, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan;
Department of Urology, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan;
Department of Urology, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan;
Department of Urology, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan;
Department of Urology, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan;
Department of Urology, Tokyo Medical University, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan;
Department of Urology, Tokyo Medical Uni;
Urothelial cancer; GC chemotherapy; Second-line chemotherapy; M-VAC failure;
机译:吉西他滨联合顺铂方案对M-VAC方案失败后晚期尿路上皮癌患者的疗效和安全性
机译:吉西他滨加卡铂;吉西他滨,多西紫杉醇和卡铂联合化疗方案治疗转移性尿路上皮癌患者,以前曾接受过铂类治疗:初步报告。
机译:每两周一次紫杉醇和吉西他滨治疗不适合顺铂治疗的晚期尿路上皮癌患者。
机译:腹腔灌注热化学疗法(CHIP)联合顺铂联合静脉化疗治疗晚期胃肠道癌的疗效
机译:与对照相比,采用两种短期疗程预防结核病,两个月利福平和吡嗪酰胺治疗或仅四个月利福平治疗,评估毒性和患者依从性的随机对照试验结果六个月异烟肼的治疗方案。
机译:甲氨蝶呤长春碱阿霉素和顺铂联合方案作为吉西他滨和顺铂化疗失败后晚期或转移性移行细胞癌患者的挽救性化疗
机译:甲氨蝶呤,长春碱,阿霉素和顺铂联合方案作为吉西他滨和顺铂化疗失败后晚期或转移性移行细胞癌患者的挽救性化疗